
The move will likely ease the worries of thousands of Indians who have been prescribed the drug for certain ailments — including malaria and autoimmune disorders like rheumatoid arthritis and lupus — but are facing difficulty in getting it after India lifted a ban on its export last week.
from Industry-Economic Times
Read The Rest:economictimes...